- Home
- GNLN vs TTNP Comparison
GNLN vs TTNP Comparison
Compare GNLN & TTNP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GNLN
- TTNP
- Stock Information
- Founded
- GNLN 2005
- TTNP 1991
- Country
- GNLN United States
- TTNP United States
- Employees
- GNLN N/A
- TTNP N/A
- Industry
- GNLN Durable Goods
- TTNP Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- GNLN Consumer Discretionary
- TTNP Health Care
- Exchange
- GNLN Nasdaq
- TTNP Nasdaq
- Market Cap
- GNLN 1.6M
- TTNP 3.4M
- IPO Year
- GNLN 2019
- TTNP 1996
- Fundamental
- Price
- GNLN $0.51
- TTNP $3.59
- Analyst Decision
- GNLN
- TTNP
- Analyst Count
- GNLN 0
- TTNP 0
- Target Price
- GNLN N/A
- TTNP N/A
- AVG Volume (30 Days)
- GNLN 325.8K
- TTNP 58.6K
- Earning Date
- GNLN 11-15-2024
- TTNP 03-31-2025
- Dividend Yield
- GNLN N/A
- TTNP N/A
- EPS Growth
- GNLN N/A
- TTNP N/A
- EPS
- GNLN N/A
- TTNP N/A
- Revenue
- GNLN $21,605,000.00
- TTNP N/A
- Revenue This Year
- GNLN $72.27
- TTNP N/A
- Revenue Next Year
- GNLN $93.46
- TTNP N/A
- P/E Ratio
- GNLN N/A
- TTNP N/A
- Revenue Growth
- GNLN N/A
- TTNP N/A
- 52 Week Low
- GNLN $0.48
- TTNP $3.03
- 52 Week High
- GNLN $21.80
- TTNP $14.80
- Technical
- Relative Strength Index (RSI)
- GNLN 18.13
- TTNP 48.42
- Support Level
- GNLN $0.51
- TTNP $3.20
- Resistance Level
- GNLN $0.58
- TTNP $4.39
- Average True Range (ATR)
- GNLN 0.06
- TTNP 0.47
- MACD
- GNLN 0.01
- TTNP -0.05
- Stochastic Oscillator
- GNLN 9.35
- TTNP 30.23
Stock Price Comparison Chart: GNLN vs TTNP
About GNLN Greenlane Holdings Inc.
Greenlane Holdings Inc is a distributor of vaporization products and consumption accessories in the United States. It offers a selection of stock-keeping units including vaporizers and parts, cleaning products, grinders and storage containers, pipes, rolling papers and customized lines of premium specialty packaging. The company markets and sells its products in both the business to business and business to consumer sectors of the marketplace. Its geographical segment includes the United States; Canada and Europe. It derives a majority of revenue from the United States.
About TTNP Titan Pharmaceuticals Inc.
Titan Pharmaceuticals Inc is a development stage company developing proprietary therapeutics with utilizing ProNeura long-term, continuous drug delivery technology. The ProNeura technology has the potential to be used in developing products for treating a number of chronic conditions, where maintaining consistent, around-the-clock blood levels of medication may benefit the patient and improve medical outcomes.